Senior insider sale
Senior Vice President, R&D at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$2.41M
60K shares
What this filing means
ROTE WILLIAM E. plans to sell 60K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $2.41M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2025ACC: 0001959173-25-007916
Officer· Senior Vice President, R&D
Since Nov 2018
60K
Shares to sell
$2.41M
Approx. market value
60K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Option Granted 02/13/2017
Cash
12/24/2025
60KTotal acquired60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/24/2025 | Option Granted 02/13/2017 Cash | 60K | — |
| Total | 60K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
60K
Market value
$2.41M
12/24/2025
Total
Units
60K
Value
$2.41M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/24/2025 | 60K | $2.41M | NASDAQ | Planned |
| Total | 60K | $2.41M | ||